Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

Enoch Muyanja, Aloysius Ssemaganda, Pearline Ngauv, +27

Journal of Clinical Investigation

Association Between Short Leukocyte Telomere Length and HIV Infection in a Cohort Study: No Evidence of a Relationship With Antiretroviral Therapy

DeAnna L. Zanet, Anona Thorne, Joel Singer, +8

Clinical Infectious Diseases

Clinical correlates of in vitro HIV-1 resistance to zidovudine. Results of the Multicentre Canadian AZT Trial

Julio Montaner, Joel Singer, Martin T. Schechter, +8

AIDS

Clinical Correlates of Human Immunodeficiency Virus–1 (HIV-1) DNA and Inducible HIV-1 RNA Reservoirs in Peripheral Blood in Children With Perinatally Acquired HIV-1 Infection With Sustained Virologic Suppression for at Least 5 Years

Ari Bitnun, Doris G. Ransy, Jason Brophy, +45

Clinical Infectious Diseases

Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial

Ralph‐Sydney Mboumba Bouassa, Eve Comeau, Yulia Alexandrova, +17

Cells

The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy – CTN PT006: study protocol for a randomized controlled trial

Bertrand Lebouché, Mohammad-Ali Jenabian, Joel Singer, +6

Trials

CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study

Cecilia T. Costiniuk, Joel Singer, Marc‐André Langlois, +18

BMJ Open